Montmorillonite, a Promising New Material for Acute Lithium Intoxication in Rats Montmorillonite in acute lithium intoxication
Iranian Journal of Pharmaceutical Sciences,
Vol. 17 No. 3 (2021),
1 Tir 2021
,
Page 71-82
https://doi.org/10.22037/ijps.v17.40275
Abstract
Lithium (Li) is considered the first-choice treatment for bipolar disorder and has a narrow therapeutic index therefore, a small increase in dose or plasma level can cause toxic effects. Gastrointestinal (GI) decontamination can be regarded as a first-line therapy for acute Li poisoning. Montmorillonite (MMT) is one of the best-known examples of a nanoclay that possesses unique properties for adsorbing substances, especially metals. We investigated the effects of MMT against acute Li intoxication. A single dose of Li (10 mEq/kg) was administered to the rats orally followed by oral gavage of MMT suspensions (0.5 or 1.0 g/kg) or activated charcoal (AC) (1g/kg) 5 min later. The serum Li concentration was measured at different times after treatment. Indeed, the serum level of sodium and potassium, WBC count, activity score, electrocardiogram, brain pathology changes, as well as pharmacokinetic parameters of Li, were evaluated. MMT at higher doses decreased the area under the curve (AUC), the elimination rate constant (Ka), the relative bioavailability (F), and increased the clearance of Li (P<0.05). MMT prevented Li induced leukocytosis, at the first sampling time, (P<0.05). It also exerted significant cardio protection, restored Li-induced ECG changes, heart rate alterations (P<0.001), and prevented Li induced hypoactivity. A similar amount of serum sodium and potassium concentration was observed in the animals. The results indicated that MMT reduced the absorption of Li, and slao possibly increased its clearance. Therefore, MMT may be a good candidate for decontamination, especially substances that are not well adsorbed by AC.
- Acute toxicity
- Clay
- Lithium
- Montmorillonite
- Chelation Therapy
- Biological Availability
How to Cite
References
[2] Waring WS. Management of lithium toxicity. Toxicol. Rev. (2006) 25:221-30.
[3] Haussmann R, Bauer M, von Bonin S, Grof P and Lewitzka U. Treatment of lithium intoxication: facing the need for evidence. Int. J. Bipolar. Disord. (2015) 3:23.
[4] Adityanjee, Munshi KR and Thampy A. The syndrome of irreversible lithium-effectuated neurotoxicity. Clin. Neuropharmacol. (2005) 28:38-49.
[5] Prencipe M, Cicchella A, Del Giudice A, Di Giorgio A, Scarlatella A, Vergura M and Aucella F. [The acute renal and cerebral toxicity of lithium: a cerebro-renal syndrome? A case report]. G. Ital. Nefrol. (2013) 30.
[6] Oruch R, Elderbi MA, Khattab HA, Pryme IF and Lund A. Lithium: a review of pharmacology, clinical uses, and toxicity. Eur. J. Pharmacol. (2014) 740:464-73.
[7] Eshel G, Barr J, Chazan S, Tavori I, Kariv N, Schejter A, Greenberg R and Berkovitch M. Efficacy of orally administered deferoxamine, activated charcoal, and sodium bicarbonate in acute iron intoxication in rats: implications for the treatment of pediatric iron poisoning. Curr. Ther. Res. Clin. Exp. (2000) 61:648-56.
[8] Satar S, Topal M and Kozaci N. Ingestion of caustic substances by adults. Am. J. Ther. (2004) 11:258-61.
[9] Uddin F. Montmorillonite: An introduction to properties and utilization. In: Zoveidavianpoor M, editor. Current Topics in the Utilization of Clay in Industrial and Medical Applications. 3th London: Headquarters IntechOpen Limited; (2018) 1.
[10] Lopez-Galindo A, Viseras C and Cerezo P. Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products. Appl. Clay Sci. (2007) 36:51-63.
[11] Dai W, Du HH, Fu LL, Liu HT and Xu ZR. Effect of montmorillonite on dietary lead (Pb) accumulation in tissues of tilapia (Oreochromis niloticus). Appl. Clay. Sci. (2010) 47:193-5.
[12] Moosavi PM, Astaraei AR, Karimi A, Moshiri M, Etemad L, Zeinali M and Karimi GR. Efficacy of orally administered montmorillonite for acute iron poisoning detoxification in rat. Appl. Clay Sci. (2015) 103:62-6.
[13] Han Z, Li J, Zhang M and Chunxia LV. Effect of montmorillonite on arsenic accumulation in common carp. Afr. J. Biotechnol. (2012) 11:6160-8.
[14] Morrison JM, Jr., Pritchard HD, Braude MC and D'Aguanno W. Plasma and brain lithium levels after lithium carbonate and lithium chloride administration by different routes in rats. Proc Soc Exp Biol Med. (1971) 137:889-92.
[15] Kmecova J and Klimas J. Heart rate correction of the QT duration in rats. Eur. J. Pharmacol. (2010) 641:187-92.
[16] Moshiri M, Vahabzadeh M, Etemad L and Hosseinzadeh H. Failure of Intravenous Lipid Emulsion to Reduce Diazinon-induced Acute Toxicity: a Pilot Study in Rats. Iran J. Pharm. Res. (2013) 12:897-902.
[17] Amitai M, Zivony A, Kronenberg S, Nagar L, Saar S, Sever J, Apter A, Shoval G, Golubchik P, Hermesh H, Weizman A and Zalsman G. Short-term effects of lithium on white blood cell counts and on levels of serum thyroid-stimulating hormone and creatinine in adolescent inpatients: a retrospective naturalistic study. J. Child Adolesc. Psychopharmacol. (2014) 24:494-500.
[18] Carmen J, Okafor K and Ike E. The effects of lithium therapy on leukocytes: a 1-year follow-up study. J. Natl. Med. Assoc. (1993) 85:301-3.
[19] Wang JS, Luo H, Billam M, Wang Z, Guan H, Tang L, Goldston T, Afriyie-Gyawu E, Lovett C, Griswold J, Brattin B, Taylor RJ, Huebner HJ and Phillips TD. Short-term safety evaluation of processed calcium montmorillonite clay (NovaSil) in humans. Food Addit. Contam. (2005) 22:270-9.
[20] Gao X, Miao R, Tao Y, Chen X, Wan C and Jia R. Effect of Montmorillonite powder on intestinal mucosal barrier in children with abdominal Henoch- Schonlein purpura: A randomized controlled study.
Medicine (Baltimore). (2018) 97:e12577.
[21] van Noord C, Straus SM, Sturkenboom MC, Hofman A, Aarnoudse AJ, Bagnardi V, Kors JA, Newton-Cheh C, Witteman JC and Stricker BH. Psychotropic drugs associated with corrected QTinterval prolongation. J. Clin. Psychopharmacol. (2009) 29:9-15.
[22] Mehta N and Vannozzi R. Lithium-induced electrocardiographic changes: A complete review. Clin. Cardiol. (2017) 40:1363-7.
[23] Tilkian AG, Schroeder JS, Kao JJ and Hultgren HN. The cardiovascular effects of lithium in man. A review of the literature. Am. J. Med. (1976)61:665-70.
[24] Armstrong EJ, Dubey A, Scheinman MM and Badhwar N. Lithium-associated Mobitz II block: case series and review of the literature. Pacing Clin. Electrophysiol. (2011) 34:e47-51.
[25] Goldberger ZD. Sinoatrial block in lithium toxicity. Am. J. Psychiatry. (2007) 164:831-2.
[26] Babich H and Stotzky G. Reductions in the toxicity of cadmium to microorganisms by clay minerals. Appl. Environ. Microbiol. (1977) 33:696-705.
[27] Abollino O, Aceto M, Malandrino M, Sarzanini C and Mentasti E. Adsorption of heavy metals on Na-montmorillonite. Effect of pH and organic substances. Water Res. (2003) 37:1619-27.
[28] Subramanian B and Gupta G. Adsorption of trace elements from poultry litter by montmorillonite clay. J. Hazard. Mater. (2006) 128:80-3.
[29] Bhattacharyya KG and Gupta SS. Influence of acid activation on adsorption of Ni (II) and Cu (II) on kaolinite and montmorillonite: kinetic and thermodynamic study. Chem. Eng. J. (2008) 136:1-13.
[30] Chen Y, Wang S, Li Y, Liu Y, Chen Y, Wu Y, Zhang J, Li H, Peng Z, Xu R and Zeng Z. Adsorption of Pb(II) by tourmaline-montmorillonite composite in aqueous phase. J. Colloid. Interface. Sci. (2020) 575:367-76.
[31] Javdani H, Khosravi R, Etemad L, Moshiri M, Zarban A and Hanafi-Bojd MY. Tannic acidtemplated mesoporous silica nanoparticles as an effective treatment in acute ferrous sulfate poisoning.Microporous and Mesoporous Materials. (2020) 307:110486.
[32] Carretero MI. Clay minerals and theirbeneficial effects upon human health. A review. Appl.Clay. Sci. (2002) 21:155-63.
[33] Bujdák J, Slosiariková H, Nováková L and Číčel B. Fixation of lithium cations in montmorillonite. Chem. Zvesti. (1991) 45:499-507.
[34] Weber JB. Molecular structure and pH effects on adsorption of 13 s-triazine compounds on montmorillonite clay. Am. Mineral. (1966) 51:1657-70.
[35] Wungu TD, Aspera SM, David MY, Dipojono HK, Nakanishi H and Kasai H. Absorption of lithium in montmorilnite: a density functional theory (DFT) study. J. Nnsci. Nanotechnol. (2011) 11:2793-801.
[36] Harward HA. chapter 70, Lithium. In: Nelson LS, Howland MA, lewin NA, Smith SW, Goldfrank LR and Homan RS, editors. Goldfranks' Toxiclogy Emergencies1th Ed New York: Mc Grow Hill; (2019). p. 1065-75.
[37] Coopr JM, Duffull SB, Saiao AS and Isbister GK. The phrmacokinetics of sertraline in overdose and the effect of activated charcoal. Br. J. Clin.
- Abstract Viewed: 574 times
- IJPS_Volume 17_Issue 3_Pages 71-82 Downloaded: 628 times